Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of corifollitropin alfa N01 in women aged 35 years or older undergoing assisted reproductive technology
CTR20263521Phase 3Active
- Sponsor
- Suzhou Shengji Pharmaceutical
- Start
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of corifollitropin alfa in infertility, sponsored by Suzhou Shengji Pharmaceutical. Started Sep 2026; status: active.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on CTR20263521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263521.